Patents by Inventor PIERRE-LOUIS HERVE

PIERRE-LOUIS HERVE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optimized epicutaneous vaccination
    Patent number: 11938178
    Abstract: The present invention relates to improved epicutaneous administration methods for vaccination of a subject. In particular, the present invention discloses the use of an antigen for epicutaneous immunization, wherein the antigen is administered by epicutaneous application with a skin patch device in combination with an epidermal skin treatment.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: March 26, 2024
    Assignees: DBV TECHNOLOGIES, BIONET-ASIA CO., LTD
    Inventors: Hong Thai Pham, Nathalie Donne, Pierre-Louis Herve, Lucie Mondoulet
  • PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION
    Publication number: 20230355737
    Abstract: The present invention relates to the epicutaneous vaccination against RSV vaccination with a skin patch device loaded with a particle exposing an RSV-F protein, a variant or a fragment thereof.
    Type: Application
    Filed: September 24, 2021
    Publication date: November 9, 2023
    Inventors: PIERRE-LOUIS HERVE, LUCIE MONDOULET, NATHALIE DONNE, ARMANDO ZUNIGA, ARIN GHASPARIAN
  • OPTIMIZED EPICUTANEOUS VACCINATION
    Publication number: 20210121556
    Abstract: The present invention relates to improved epicutaneous administration methods for vaccination of a subject. In particular, the present invention discloses the use of an antigen for epicutaneous immunization, wherein the antigen is administered by epicutaneous application with a skin patch device in combination with an epidermal skin treatment.
    Type: Application
    Filed: July 9, 2019
    Publication date: April 29, 2021
    Inventors: HONG THAI PHAM, NATHALIE DONNE, PIERRE-LOUIS HERVE, LUCIE MONDOULET